Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.

The nature of protective immune responses elicited by immunization with the candidate malaria vaccine RTS,S is still incompletely understood. Antibody levels correlate with protection against malaria infection, but considerable variation in outcome is unexplained (e.g., children may experience malar...

Full description

Bibliographic Details
Main Authors:	Ally Olotu, Frederic Clement, Erik Jongert, Johan Vekemans, Patricia Njuguna, Francis M Ndungu, Kevin Marsh, Geert Leroux-Roels, Philip Bejon
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4266636?pdf=render

Similar Items

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.
by: Francis M Ndungu, et al.
Published: (2012-01-01)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
by: Ally Olotu, et al.
Published: (2011-01-01)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
by: Carlota Dobaño, et al.
Published: (2019-05-01)

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection
by: Kelly E. Seaton, et al.
Published: (2021-08-01)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
by: Juliette Fortpied, et al.
Published: (2020-06-01)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children [version 1; peer review: 1 approved, 2 approved with reservations]
by: Francis M. Ndungu, et al.
Published: (2019-03-01)

Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
by: Frances Ibison, et al.
Published: (2012-01-01)

Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite <it>Plasmodium falciparum</it>
by: Clement Frederic, et al.
Published: (2012-11-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
by: John Lusingu, et al.
Published: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
by: John Lusingu, et al.
Published: (2010-11-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
by: John Lusingu, et al.
Published: (2010-01-01)

Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
by: Mohammad Zeeshan, et al.
Published: (2012-01-01)

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D).
by: Selidji T Agnandji, et al.
Published: (2011-04-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
by: John Lusingu, et al.
Published: (2010-01-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
by: John Lusingu, et al.
Published: (2010-01-01)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
by: Daniel Ansong, et al.
Published: (2011-04-01)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care
by: Vekemans Johan, et al.
Published: (2011-08-01)

T-dependent B cell responses to Plasmodium induce antibodies that form a high-avidity multivalent complex with the circumsporozoite protein.
by: Camilla R Fisher, et al.
Published: (2017-07-01)

Avid binding by B cells to the Plasmodium circumsporozoite protein repeat suppresses responses to protective subdominant epitopes
by: Deepyan Chatterjee, et al.
Published: (2021-04-01)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.
by: Michael T White, et al.
Published: (2013-01-01)

A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses
by: Suresh Pallikkuth, et al.
Published: (2020-04-01)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
by: Mark E Polhemus, et al.
Published: (2009-07-01)

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa
by: Macete Eusebio, et al.
Published: (2011-08-01)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
by: Seth Owusu-Agyei, et al.
Published: (2010-01-01)

Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.
by: Christian F Ockenhouse, et al.
Published: (2015-01-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
by: Seth Owusu-Agyei, et al.
Published: (2009-10-01)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
by: Roly Gosling, et al.
Published: (2016-04-01)

Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis
by: Sidhartha Chaudhury, et al.
Published: (2017-08-01)

Correction: Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
by: Seth Owusu-Agyei, et al.
Published: (2010-01-01)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
by: Robert A. van den Berg, et al.
Published: (2017-05-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
by: Griffin J. Bell, et al.
Published: (2020-06-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
by: John N Waitumbi, et al.
Published: (2009-11-01)

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine
by: Carter Terrell, et al.
Published: (2011-08-01)

A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.
by: Bertrand Lell, et al.
Published: (2009-10-01)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children
by: Lievens Marc, et al.
Published: (2011-08-01)

Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
by: Alan Brooks, et al.
Published: (2012-01-01)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
by: Arora N, et al.
Published: (2021-03-01)

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
by: Sonia Budroni, et al.
Published: (2021-05-01)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
by: Stephaney Gyaase, et al.
Published: (2021-01-01)

Monoclonal Antibodies against Plasmodium falciparum Circumsporozoite Protein
by: Min Zhang, et al.
Published: (2017-08-01)

Cannot write session to /tmp/vufind_sessions/sess_87nia2k2ummnq0ensnhfdv8jtv